- Home
- FMBH vs RCUS Comparison
FMBH vs RCUS Comparison
Compare FMBH & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- RCUS
- Stock Information
- Founded
- FMBH 1865
- RCUS 2015
- Country
- FMBH United States
- RCUS United States
- Employees
- FMBH N/A
- RCUS N/A
- Industry
- FMBH Major Banks
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- RCUS Health Care
- Exchange
- FMBH Nasdaq
- RCUS Nasdaq
- Market Cap
- FMBH 853.8M
- RCUS 906.4M
- IPO Year
- FMBH N/A
- RCUS 2018
- Fundamental
- Price
- FMBH $37.70
- RCUS $8.15
- Analyst Decision
- FMBH Hold
- RCUS Buy
- Analyst Count
- FMBH 5
- RCUS 10
- Target Price
- FMBH $44.00
- RCUS $23.75
- AVG Volume (30 Days)
- FMBH 79.8K
- RCUS 1.2M
- Earning Date
- FMBH 07-31-2025
- RCUS 08-07-2025
- Dividend Yield
- FMBH 2.51%
- RCUS N/A
- EPS Growth
- FMBH 8.80
- RCUS N/A
- EPS
- FMBH 3.37
- RCUS N/A
- Revenue
- FMBH $321,695,000.00
- RCUS $141,000,000.00
- Revenue This Year
- FMBH N/A
- RCUS N/A
- Revenue Next Year
- FMBH $4.02
- RCUS $28.73
- P/E Ratio
- FMBH $11.34
- RCUS N/A
- Revenue Growth
- FMBH 11.71
- RCUS N/A
- 52 Week Low
- FMBH $27.58
- RCUS $6.50
- 52 Week High
- FMBH $43.86
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- FMBH 62.20
- RCUS 39.72
- Support Level
- FMBH $36.53
- RCUS $7.91
- Resistance Level
- FMBH $37.35
- RCUS $8.87
- Average True Range (ATR)
- FMBH 0.99
- RCUS 0.49
- MACD
- FMBH 0.12
- RCUS -0.15
- Stochastic Oscillator
- FMBH 99.18
- RCUS 10.11
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.